Ryan Leahy

Vice President of Research • Phacilitate

Ry is an avid science communication professional who is currently the Vice President of Research and Head of Content for Phacilitate and a Visiting Academic at the University of Oxford.

He is engaged in the increase of effective scientific communication to a variety of stakeholders and populations to advance the development of and access to cell and gene therapies. He’s a major proponent for expedited manufacturing and reduction of cost-of-goods, increased market and patient access, and a progressive approach to advanced therapies that considers and incorporates the patient voice at every step of the research, development and commercialization journey.

Ry has developed the last two Phacilitate Advanced Therapies Week meetings and is responsible for the content therein; if you have any questions about the agenda, feedback, or would like to discuss next year’s meeting, he’d be excited to talk.

Ryan is a patient & patient advocate for Eosinophilic Esophagitis and several related conditions, and is part of both APFED (American Partnership for Eosinophilic Disorders) and EOS Network.

Ry holds an MSc from the University of Oxford, is a mental health first-aider, and a proponent for DE&I support initiatives both within Phacilitate and throughout the Advanced Therapies Workforce.

Also Speaking

Sujay Kango

Chief Executive Officer • Tmunity

Ohad Karneili

Chief Executive Officer • Adva Biotechnology

Miranda Neville

Vice President Global Operations & Delivery • Autolus

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.